Skip to main content
Atrás
Watch Compare

CervoMed Inc.

Calidad de datos: 100%
CRVO
Nasdaq Manufacturing Chemicals
$3.83
▼ $0.20 (-4.96%)
Cap. Mercado: 37.03 M
Precio
$4.00
Cap. Mercado
37.03 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -23.45 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-58.86%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-90.72%
Below sector avg (-53.47%)
ROIC-65.08%
Net Margin-673.06%
Op. Margin-706.22%

Seguridad

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valoración

PE (TTM)
-1.37
Above sector avg (-1.48)
P/B Ratio1.42
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.4 -1.5
P/B 1.4 1.6
ROE % -90.7 -53.5
Net Margin % -673.1 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

7 analistas
Buy
Actual
$3.83
+478.1%
Objetivo
$22.14
$11.00
$21.00
$31.00
Pronóstico
P/E Futuro -2.26
EPS Futuro -$1.69
Ingresos Est. 625,000.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$1.69
-$2.44 – -$0.34
 625,000.0 6
FY2026 -$2.38
-$4.34 – -$0.54
 350,000.0 7

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.70 -$0.88 -25.4%
Q32025 -$0.64 -$0.84 -31.6%
Q22025 -$0.62 -$0.70 -13.3%
Q12025 -$0.62 -$0.56 +10.2%

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -58.86% Revenue Growth (3Y) -25.12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.01 M Net Income (TTM) -26.97 M
ROE -90.72% ROA -78.51%
Gross Margin N/A Operating Margin -706.22%
Net Margin -673.06% Free Cash Flow (TTM) -23.45 M
ROIC -65.08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0.12
Working Capital N/A Tangible Book Value 26.01 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.37 Forward P/E N/A
P/B Ratio 1.42 P/S Ratio 9.24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -63.32%
Market Cap 37.03 M Enterprise Value 27.60 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.43
FCF / Share -2.53 OCF / Share -2.53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.96%
SBC-Adj. FCF -24.87 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.01 M 9.74 M 7.14 M — —
Net Income -26.97 M -16.29 M -2.17 M -15.59 M -24.10 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -28.29 M -18.23 M -7.81 M -15.97 M -24.68 M
EBITDA — — — — —
R&D Expenses 21.82 M 18.80 M 8.44 M 7.24 M 8.50 M
SG&A Expenses — — — — —
D&A — — — 0.0 93,416.0
Interest Expense — — 0.0 — —
Income Tax 0.0 — — 0.0 -443,893.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22.88 M 43.08 M 9.97 M 22.64 M 37.84 M
Total Liabilities 4.66 M 3.88 M 2.60 M 2.42 M 2.93 M
Shareholders' Equity 18.22 M 39.20 M 7.38 M 20.22 M 34.91 M
Total Debt — — — — —
Cash & Equivalents 8.24 M 9.00 M 7.79 M 10.11 M 37.31 M
Current Assets 22.88 M 43.08 M 9.96 M 22.64 M 37.82 M
Current Liabilities 4.66 M — — — 2.93 M